The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet DNA Vaccines Market Research Report 2025
Synopsis
DNA vaccines are the direct application of antigen-encoding DNA vectors.
Introduce into the body, express the protein, and then pass through the cells and body fluids
The immune response to produce antibodies, to achieve a method of prevention and treatment of disease.
The global Pet DNA Vaccines market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 107.2 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 377%.
This report aims to provide a comprehensive presentation of the global market for Pet DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet DNA Vaccines.
Report Scope
The Pet DNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet DNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet DNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Pfizer
Ringpu
Segment by Type
Rabies Vaccine
Others
Segment by Application
Dog
Cat
Dird
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet DNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
DNA vaccines are the direct application of antigen-encoding DNA vectors.
Introduce into the body, express the protein, and then pass through the cells and body fluids
The immune response to produce antibodies, to achieve a method of prevention and treatment of disease.
The global Pet DNA Vaccines market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 107.2 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 377%.
This report aims to provide a comprehensive presentation of the global market for Pet DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet DNA Vaccines.
Report Scope
The Pet DNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet DNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet DNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Pfizer
Ringpu
Segment by Type
Rabies Vaccine
Others
Segment by Application
Dog
Cat
Dird
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet DNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pet DNA Vaccines Market Overview
1.1 Product Overview and Scope of Pet DNA Vaccines
1.2 Pet DNA Vaccines Segment by Type
1.2.1 Global Pet DNA Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Rabies Vaccine
1.2.3 Others
1.3 Pet DNA Vaccines Segment by Application
1.3.1 Global Pet DNA Vaccines Market Value by Application: (2024-2030)
1.3.2 Dog
1.3.3 Cat
1.3.4 Dird
1.3.5 Others
1.4 Global Pet DNA Vaccines Market Size Estimates and Forecasts
1.4.1 Global Pet DNA Vaccines Revenue 2019-2030
1.4.2 Global Pet DNA Vaccines Sales 2019-2030
1.4.3 Global Pet DNA Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pet DNA Vaccines Market Competition by Manufacturers
2.1 Global Pet DNA Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pet DNA Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pet DNA Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Pet DNA Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet DNA Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet DNA Vaccines, Product Type & Application
2.7 Pet DNA Vaccines Market Competitive Situation and Trends
2.7.1 Pet DNA Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet DNA Vaccines Players Market Share by Revenue
2.7.3 Global Pet DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet DNA Vaccines Retrospective Market Scenario by Region
3.1 Global Pet DNA Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pet DNA Vaccines Global Pet DNA Vaccines Sales by Region: 2019-2030
3.2.1 Global Pet DNA Vaccines Sales by Region: 2019-2024
3.2.2 Global Pet DNA Vaccines Sales by Region: 2025-2030
3.3 Global Pet DNA Vaccines Global Pet DNA Vaccines Revenue by Region: 2019-2030
3.3.1 Global Pet DNA Vaccines Revenue by Region: 2019-2024
3.3.2 Global Pet DNA Vaccines Revenue by Region: 2025-2030
3.4 North America Pet DNA Vaccines Market Facts & Figures by Country
3.4.1 North America Pet DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pet DNA Vaccines Sales by Country (2019-2030)
3.4.3 North America Pet DNA Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pet DNA Vaccines Market Facts & Figures by Country
3.5.1 Europe Pet DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pet DNA Vaccines Sales by Country (2019-2030)
3.5.3 Europe Pet DNA Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet DNA Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Pet DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pet DNA Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Pet DNA Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pet DNA Vaccines Market Facts & Figures by Country
3.7.1 Latin America Pet DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pet DNA Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Pet DNA Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet DNA Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pet DNA Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pet DNA Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet DNA Vaccines Sales by Type (2019-2030)
4.1.1 Global Pet DNA Vaccines Sales by Type (2019-2024)
4.1.2 Global Pet DNA Vaccines Sales by Type (2025-2030)
4.1.3 Global Pet DNA Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Pet DNA Vaccines Revenue by Type (2019-2030)
4.2.1 Global Pet DNA Vaccines Revenue by Type (2019-2024)
4.2.2 Global Pet DNA Vaccines Revenue by Type (2025-2030)
4.2.3 Global Pet DNA Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Pet DNA Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pet DNA Vaccines Sales by Application (2019-2030)
5.1.1 Global Pet DNA Vaccines Sales by Application (2019-2024)
5.1.2 Global Pet DNA Vaccines Sales by Application (2025-2030)
5.1.3 Global Pet DNA Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Pet DNA Vaccines Revenue by Application (2019-2030)
5.2.1 Global Pet DNA Vaccines Revenue by Application (2019-2024)
5.2.2 Global Pet DNA Vaccines Revenue by Application (2025-2030)
5.2.3 Global Pet DNA Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Pet DNA Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer Healthcare
6.1.1 Bayer Healthcare Corporation Information
6.1.2 Bayer Healthcare Description and Business Overview
6.1.3 Bayer Healthcare Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Healthcare Pet DNA Vaccines Product Portfolio
6.1.5 Bayer Healthcare Recent Developments/Updates
6.2 Vetoquinol S.A
6.2.1 Vetoquinol S.A Corporation Information
6.2.2 Vetoquinol S.A Description and Business Overview
6.2.3 Vetoquinol S.A Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Vetoquinol S.A Pet DNA Vaccines Product Portfolio
6.2.5 Vetoquinol S.A Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Pet DNA Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Pet DNA Vaccines Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eli Lilly Pet DNA Vaccines Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Heska
6.6.1 Heska Corporation Information
6.6.2 Heska Description and Business Overview
6.6.3 Heska Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Heska Pet DNA Vaccines Product Portfolio
6.6.5 Heska Recent Developments/Updates
6.7 Merck Animal Health
6.6.1 Merck Animal Health Corporation Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Animal Health Pet DNA Vaccines Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 Merial (Sanofi)
6.8.1 Merial (Sanofi) Corporation Information
6.8.2 Merial (Sanofi) Description and Business Overview
6.8.3 Merial (Sanofi) Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merial (Sanofi) Pet DNA Vaccines Product Portfolio
6.8.5 Merial (Sanofi) Recent Developments/Updates
6.9 Virbac
6.9.1 Virbac Corporation Information
6.9.2 Virbac Description and Business Overview
6.9.3 Virbac Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Virbac Pet DNA Vaccines Product Portfolio
6.9.5 Virbac Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pfizer Pet DNA Vaccines Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 Ringpu
6.11.1 Ringpu Corporation Information
6.11.2 Ringpu Pet DNA Vaccines Description and Business Overview
6.11.3 Ringpu Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Ringpu Pet DNA Vaccines Product Portfolio
6.11.5 Ringpu Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet DNA Vaccines Industry Chain Analysis
7.2 Pet DNA Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet DNA Vaccines Production Mode & Process
7.4 Pet DNA Vaccines Sales and Marketing
7.4.1 Pet DNA Vaccines Sales Channels
7.4.2 Pet DNA Vaccines Distributors
7.5 Pet DNA Vaccines Customers
8 Pet DNA Vaccines Market Dynamics
8.1 Pet DNA Vaccines Industry Trends
8.2 Pet DNA Vaccines Market Drivers
8.3 Pet DNA Vaccines Market Challenges
8.4 Pet DNA Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pet DNA Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pet DNA Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pet DNA Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pet DNA Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pet DNA Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pet DNA Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pet DNA Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pet DNA Vaccines Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pet DNA Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pet DNA Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pet DNA Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Pet DNA Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pet DNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet DNA Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pet DNA Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pet DNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 18. Global Pet DNA Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Pet DNA Vaccines Sales by Region (2025-2030) & (K Units)
Table 20. Global Pet DNA Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Pet DNA Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pet DNA Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Pet DNA Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pet DNA Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Pet DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pet DNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 27. North America Pet DNA Vaccines Sales by Country (2025-2030) & (K Units)
Table 28. North America Pet DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pet DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pet DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pet DNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pet DNA Vaccines Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pet DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pet DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pet DNA Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pet DNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pet DNA Vaccines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pet DNA Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pet DNA Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pet DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pet DNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pet DNA Vaccines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pet DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pet DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pet DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pet DNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Pet DNA Vaccines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Pet DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pet DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pet DNA Vaccines Sales (K Units) by Type (2019-2024)
Table 51. Global Pet DNA Vaccines Sales (K Units) by Type (2025-2030)
Table 52. Global Pet DNA Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Pet DNA Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Pet DNA Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pet DNA Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pet DNA Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Pet DNA Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Pet DNA Vaccines Price (US$/Unit) by Type (2019-2024)
Table 59. Global Pet DNA Vaccines Price (US$/Unit) by Type (2025-2030)
Table 60. Global Pet DNA Vaccines Sales (K Units) by Application (2019-2024)
Table 61. Global Pet DNA Vaccines Sales (K Units) by Application (2025-2030)
Table 62. Global Pet DNA Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Pet DNA Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Pet DNA Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pet DNA Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pet DNA Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Pet DNA Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Pet DNA Vaccines Price (US$/Unit) by Application (2019-2024)
Table 69. Global Pet DNA Vaccines Price (US$/Unit) by Application (2025-2030)
Table 70. Bayer Healthcare Corporation Information
Table 71. Bayer Healthcare Description and Business Overview
Table 72. Bayer Healthcare Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bayer Healthcare Pet DNA Vaccines Product
Table 74. Bayer Healthcare Recent Developments/Updates
Table 75. Vetoquinol S.A Corporation Information
Table 76. Vetoquinol S.A Description and Business Overview
Table 77. Vetoquinol S.A Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Vetoquinol S.A Pet DNA Vaccines Product
Table 79. Vetoquinol S.A Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Pet DNA Vaccines Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Ceva Corporation Information
Table 86. Ceva Description and Business Overview
Table 87. Ceva Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Ceva Pet DNA Vaccines Product
Table 89. Ceva Recent Developments/Updates
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Eli Lilly Pet DNA Vaccines Product
Table 94. Eli Lilly Recent Developments/Updates
Table 95. Heska Corporation Information
Table 96. Heska Description and Business Overview
Table 97. Heska Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Heska Pet DNA Vaccines Product
Table 99. Heska Recent Developments/Updates
Table 100. Merck Animal Health Corporation Information
Table 101. Merck Animal Health Description and Business Overview
Table 102. Merck Animal Health Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Merck Animal Health Pet DNA Vaccines Product
Table 104. Merck Animal Health Recent Developments/Updates
Table 105. Merial (Sanofi) Corporation Information
Table 106. Merial (Sanofi) Description and Business Overview
Table 107. Merial (Sanofi) Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Merial (Sanofi) Pet DNA Vaccines Product
Table 109. Merial (Sanofi) Recent Developments/Updates
Table 110. Virbac Corporation Information
Table 111. Virbac Description and Business Overview
Table 112. Virbac Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Virbac Pet DNA Vaccines Product
Table 114. Virbac Recent Developments/Updates
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Pfizer Pet DNA Vaccines Product
Table 119. Pfizer Recent Developments/Updates
Table 120. Ringpu Corporation Information
Table 121. Ringpu Description and Business Overview
Table 122. Ringpu Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Ringpu Pet DNA Vaccines Product
Table 124. Ringpu Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Pet DNA Vaccines Distributors List
Table 128. Pet DNA Vaccines Customers List
Table 129. Pet DNA Vaccines Market Trends
Table 130. Pet DNA Vaccines Market Drivers
Table 131. Pet DNA Vaccines Market Challenges
Table 132. Pet DNA Vaccines Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pet DNA Vaccines
Figure 2. Global Pet DNA Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pet DNA Vaccines Market Share by Type in 2023 & 2030
Figure 4. Rabies Vaccine Product Picture
Figure 5. Others Product Picture
Figure 6. Global Pet DNA Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pet DNA Vaccines Market Share by Application in 2023 & 2030
Figure 8. Dog
Figure 9. Cat
Figure 10. Dird
Figure 11. Others
Figure 12. Global Pet DNA Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Pet DNA Vaccines Market Size (2019-2030) & (US$ Million)
Figure 14. Global Pet DNA Vaccines Sales (2019-2030) & (K Units)
Figure 15. Global Pet DNA Vaccines Average Price (US$/Unit) & (2019-2030)
Figure 16. Pet DNA Vaccines Report Years Considered
Figure 17. Pet DNA Vaccines Sales Share by Manufacturers in 2023
Figure 18. Global Pet DNA Vaccines Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Pet DNA Vaccines Players: Market Share by Revenue in 2023
Figure 20. Pet DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Pet DNA Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Pet DNA Vaccines Sales Market Share by Country (2019-2030)
Figure 23. North America Pet DNA Vaccines Revenue Market Share by Country (2019-2030)
Figure 24. United States Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Pet DNA Vaccines Sales Market Share by Country (2019-2030)
Figure 27. Europe Pet DNA Vaccines Revenue Market Share by Country (2019-2030)
Figure 28. Germany Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Pet DNA Vaccines Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Pet DNA Vaccines Revenue Market Share by Region (2019-2030)
Figure 35. China Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Pet DNA Vaccines Sales Market Share by Country (2019-2030)
Figure 45. Latin America Pet DNA Vaccines Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Pet DNA Vaccines Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Pet DNA Vaccines Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Pet DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Pet DNA Vaccines by Type (2019-2030)
Figure 55. Global Revenue Market Share of Pet DNA Vaccines by Type (2019-2030)
Figure 56. Global Pet DNA Vaccines Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Pet DNA Vaccines by Application (2019-2030)
Figure 58. Global Revenue Market Share of Pet DNA Vaccines by Application (2019-2030)
Figure 59. Global Pet DNA Vaccines Price (US$/Unit) by Application (2019-2030)
Figure 60. Pet DNA Vaccines Value Chain
Figure 61. Pet DNA Vaccines Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
